The study: Multi-centre, prospective, single-blinded (assessors were blinded) randomised controlled trial (RCT).
The study patients:
All adults admitted to 36 intensive care units (ICU) in Europe and Australia between November 2010 and January 2013. Eligibility: Patients of at least 18 years of age admitted following out-of-hospital cardiac arrest of presumed cardiac cause. Inclusion criteria: Unconscious patients with a GCS <8 on admission to hospital with more than 20 consecutive minutes of spontaneous circulation restored after resuscitation. Exclusion criteria: An interval from the return of spontaneous circulation to screening of more than 240 minutes; unwitnessed arrest with asystole as the initial rhythm; suspected or known acute intracranial haemorrhage or stroke; and a body temperature of less than 30°C on admission.
Study method:
Following screening and random allocation to one of the two targeted temperature management groups, patients were cooled to the target temperature as rapidly as possible with the use of ice-cold fluids, ice packs and intravascular or surface temperature management devices at the discretion of the treating team.
The intervention period of 36 hours commenced at the time of randomisation. Sedation was mandated in both groups until the end of the intervention period.
After 28 hours, gradual rewarming to 37°C in hourly increments of 0.5°C was commenced in both groups. At 36 hours, sedation was discontinued or tapered. After the intervention period, the intention was to maintain the body temperature for unconscious patients below 37.5°C until 72 hours after the cardiac arrest, with the use of fever-control measures at the discretion of the treating team.
A physician who was unaware of the intervention assignments performed a neurological evaluation 72 hours after the end of the intervention for patients who remained unconscious and issued a recommendation for the continuation or withdrawal of therapy. The trial protocol established pre-specified criteria for withdrawal of lifesustaining therapy. All clinical decisions remained at the discretion of the treating team.
Targeted temperature management at 33°C versus 36°C after cardiac arrest 2C04, 3C00
In unconscious survivors of out-of-hospital cardiac arrest of presumed cardiac cause, hypothermia at a targeted temperature of 33°C did not confer a benefit compared to a targeted temperature of 36°C.
Level of evidence: 1B (CEBM-RCT with narrow CIs)
Appraised by: A Claxton, R Saha 
CAT reviews
All surviving patients were followed until 180 days after the enrolment of the last patient.
In both the CPC scale and modified Rankin scale, lower scores represent better cerebral performance. Poor neurological function was defined as a CPC of 3-5 and a Modified Rankin scale score of 4-6.
EBM questions: 1. Do the methods allow accurate testing of the hypothesis? Yes.
Randomisation was computer-generated in permuted blocks of varying size and stratified according to site. The study was single-blinded by necessity, as treating teams would need to know the targeted temperature of their patients. All outcome assessors, study administrators, statisticians and authors were unaware of the intervention assignments.
Do the statistical tests correctly test the results to allow
differentiation of statistically significant results? Yes. The Wilcoxon signed-rank test was used to compare the distributions of continuous outcome measures. Logistic regression and Cox analyses were used to adjust for covariates. All tests were two-sided and adjusted for multiple comparisons, p values <0.05 were considered statistically significant. 3. Are the conclusions valid in light of the results? Yes. The authors concluded that this study did not provide evidence that targeting a body temperature of 33°C confers any benefit for unconscious patients admitted to the hospital after out-of-hospital cardiac arrest, as compared with targeting a body temperature of 36°C. 4. Did any results get omitted and why? Yes. Of the 950 patients who underwent randomisation, eleven were excluded (three from the 33°C and eight from the 36°C groups respectively). Of these, one was not admitted to ICU after randomisation due to treatment limitation decisions, one was awake and four were withdrawn at the patient' s or surrogate' s request. Of the remaining five patients excluded, three had no recorded cardiac arrest, one had a non-cardiac cause of cardiac arrest and one had a subarachnoid haemorrhage, diagnosed immediately after randomisation. 5. Did the authors suggest areas for further research? No. 6. Did the authors make any recommendations based on the results and were they appropriate? No. However the authors did state that decisions about which temperature to target after out-of-hospital cardiac arrest require careful consideration. They also state that it is important to acknowledge that there may be a clinically relevant benefit of controlling the body temperature at 36°C, instead of allowing fever to develop in these patients. 7. Is this study relevant to my clinical practice? Yes. The patients were a heterogeneous group similar in demographics to patients treated in ICUs in the UK. 8. What level of evidence does this study represent? 1B: a randomised controlled trial of good quality. It was not feasible to blind treating teams and therefore the study may carry a risk of bias.
What grade of recommendation can I make based on this result alone?
A. This trial showed there to be no statistical advantage in managing the temperature of patients at either 33°C or 36°C following out-of-hospital cardiac arrest. 10.What grade of recommendation can I make when this study is considered alongside other available evidence? B. Two previous RCTs, in unconscious patients after resuscitation from cardiac arrest (of presumed cardiac cause, with an initial shockable rhythm), found significant improvement in neurological function and survival in those receiving therapeutic hypothermia (32°C to 34°C for 12 to 24 hours) compared with standard treatment.
11.Should I change my practice based upon these results?
Possibly. This study showed no difference in outcome for patients managed with therapeutic hypothermia compared to maintaining normothermia following cardiac arrest. However, international guidelines based on the results of previous studies recommend therapeutic hypothermia post cardiac arrest. 1 The study population in this trial is not easily comparable with those in previous trials, as the previous trials were in the setting of cardiac arrest with an initial shockable rhythm. 2, 3 In contrast, in this study approximately 20% of participants had non-shockable rhythms. Furthermore the study population may differ from those in previous studies due to the advancement of prehospital and intensive care practice over time. This may have reduced the potential benefits of a single intervention.
In the previous studies, the commonest cause of death was withdrawal of life support because of perceived poor neurological prognosis. 2 This is a potential confounder because there are no certain methods to establish long-term prognosis. In this study there was a clearly delineated approach for the 26% of patients who had withdrawal of life-sustaining therapy. 12.Should I audit my own practice based upon these results? Yes.
